Blood pressure variability in established L-NAME hypertension in rats

Journal of Hypertension

Volumn 17, Issue 11, 1999, Pages 1527-1534

  Blanc, Jocelyne ^a   Ponchon, Pascal ^a   Laude, Dominique ^a   Elghozi, Jean Luc ^a   Jover, Bernard ^b  

^a CNRS   (France)

^b UNIV MONTPELLIER   (France)

Author keywords

Angiotensin type 1 receptor antagonist; Nitric oxide; Poincare plot; Sympathetic nervous system

Indexed keywords

LOSARTAN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PRAZOSIN;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; VARIANCE;

EID: 0032751163     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199917110-00004     Document Type: Article

References (29)

1. Gouédard O, Blanc J, Gaudet E, Ponchon P, Elghozi JL. Contribution of the renin - angiotensin system to short-term blood pressure variability during blockade of nitric oxide synthesis in the rat. Br J Pharmacol 1996; 119:1085-1092.
2. Persson PB, Baumann JE, Ehmke H, Nafz B, Wittmann U, Kirchheim HR. Phasic and 24-h blood pressure control by endothelium-derived relaxing factor in conscious dogs. Am J Physiol 1992; 262:H1395-H1400.
3. [t]-monomethyl-L-arginine on short-term RR interval and systolic blood pressure oscillations. J Cardiovasc Pharmacol 1994; 24:323-327.
4. Nafz B, Wagner CD, Persson PB, Endogenous nitric oxide buffers blood pressure variability between 0.2 and 0.6 Hz in the conscious rat. Am J Physiol 1997; 272:H632-H637.
5. Jover B, Herizi A, Ventre F, Dupont M, Mimran A, Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade. Hypertension 1993; 21:944-948.
6. Matsuoka H, Nishida H, Nomura G, Van Vliet BN, Toshima H. Hypertension induced by nitric oxide synthesis inhibition is renal nerve dependent. Hypertension 1994; 23:971-975.
7. Sander M, Hansen PG, Victor RG. Sympathetically mediated hypertension caused by chonic inhibition of nitric oxide. Hypertension 1995; 26:691-695.
8. Radaelli A, Mircoli L, Perlini S, Bolla G, Mori I, Mancia G, et al. Lack of autonomic contributions to tonic nitric oxide-mediated vasodilatation in unanesthetized free-moving rats. J Hypertens 1998; 16:55-61.
9. Julien C, Zhang ZQ, Cerutti C, Barres C. Hemodynamic analysis of arterial pressure oscillations in conscious rats. J Auton Nerv Syst 1995; 50:239-252.
10. Ponchon P, Elghozi JL. Contribution of the renin-angiotensin and kallikrein - kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats. Eur J Pharmacol 1996; 297:61-70.
11. Manning RD, Hu L, Mizelle HL, Montani JP, Norton MW. Cardiovascular responses to long-term blockade of nitric oxide synthesis. Hypertension 1993; 22:40-48.
12. Grichois ML, Blanc J, Deckert V, Elghozi JL, Differential effects of enalapril and hydralazine on short-term variability of blood pressure and heart rate in rats. J Cardiovasc Pharmacol 1992; 19:863-869.
13. Japundzic N, Grichois ML, Zitoun P, Laude D, Elghozi JL. Spectral analysis of blood pressure and heart rate in conscious rats: effects of autonomic blockers. J Auton Nerv Syst 1990; 30:91-100.
14. Kamen PW, Tonkin AM. Application of the Poincaré plot to heart rate variability: a new measure of functional status in heart failure. Aust NZ Med 1995; 25:18-26.
15. Woo MA, Stevenson WG, Moser DK, Trelease RB, Harper RM. Patterns of beat-to-beat heart rate variability in advanced heart failure. Am Heart J 1992; 123:704-710.
16. Castellano M, Rizzoni D, Beschi M, Muisean ML, Porteri E, Bettoni G, et al. Relationship between sympathetic nervous system activity, baroreflex and cardiovascular effects after acute nitric oxide synthesis inhibition in humans, J Hypertens 1995; 13:1153-1161.
17. Rizzoni D, Castellano M, Porteri E, Bettoni G, Muisean P, Muisean ML, et al. Arterial spontaneous rhythmic contractile activity in humans and rats: spectral analysis and regulatory mechanims. J Hypertens 1995; 13:1043-1052.
18. Bertuglia S, Colantuoni A, Intaglietta M. Effects of L-NMMA and indomethacin on arteriolar vasomotion in skeletal muscle microcirculation of conscious and anesthetized hamsters. Microvasc Res 1994; 48:68-84.
19. Bouriquet N, Casellas D. Chronic L-NAME hypertension in rats and autoregulation of juxtamedullary preglomerular vessels. Am J Physiol 1995; 269:F190-F197.
20. Bouriquet N, Dupont M, Herizi A, Mimran A, Casellas D. Preglomerular sudanophilia in L-NAME hypertensive rats. Involvement of endothelin. Hypertension 1996; 27:382-391.
21. Gaudet E, Blanc J, Elghozi JL. Effects of losartan on short-term variability of blood pressure in SHR and WKY rats. Fundam Clin Pharmacol 1995; 9:30-36.
22. (t)-nitro-L-arginine methyl ester. Hypertension 1995; 30:64-70.
23. Sakuma I, Togashi H, Yoshioka M, Saito H, Yanagida M, Tamura M, et al. NG-methyl-L-arginine, an inhibitor of L-arginine-derived nitric oxide synthesis, stimulates renal sympathetic nerve activity in vivo. Circ Res 1992; 70:607-611.
24. Zanchi A, Schaad NC, Osterfheld MC, Grouzmann E, Nussberger J, Brunner HR, et al. Effects of chronic NO synthase inhibition in rats on reninangiotersin system and sympathetic nervous system. Am J Physiol 1995; 268:H2267-H2273.
25. Granger J, Schnackenberg C, Novak J, Tucker B, Miller T, Moran S, et al. Role of nitric oxide in modulating the long-term renal and hypertensive actions of norepinephrine. Hypertension 1997; 29:205-209.
26. Kurihara N, Alfie ME, Sigmon DH, Rhaleb NE, Shesely EG, Carretero OA. Role of nNOS in blood pressure regulation in eNOS null mutant mice. Hypertension 1998; 32:856-881.
27. Scrogin KE, Hatton DC, Chi Y, Luft FG. Chronic nitric oxide inhibition with L-NAME: effects on autonomic control of the cardiovascular system. Am J Physiol 1998; 274:R367-R374.
28. Garcia-Estan J, Navarro J, Atucha NM, Quesada T, Romero JC, Cachofeiro V, et al. Chronic effects of nitric oxide and prostaglandin inhibition on pressure diuresis and natriuresis in rats. Kidney Int 1996; 49 (suppl 55):S141-S143.
29. Baylis C, Mitruka B, Deng A. Chronic blockade of nitric oxide synthesis in the rat produces systemic hypertension and glomerular damage. J Clin Invest 1992; 90:278-281.